Awarded
Lote 1. Ravulizumab (Ultomiris).
Original language: Spanish
- Contract value
- €5,854,033
- Bids received
- 1
- Published
- 3 Aug 2026
- Awarded
- 31 Jul 2026
- Contract start
- 31 Jul 2026
- Contract end
- 18 Aug 2027estimated
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| Contratación del servicio de realización de análisis y estudios anatomopatológicos de muestras biológicas del Hospital Comarcal de Laredo. | Servicio Cántabro de Salud | ANAPATH,S.L.U., ATRYS HEALTH SA, MAZORRA Y VELA PATÓLOGOS, S.L.P. | €121,300 | 22 Oct 2026 |
| Lote 12. Lyvdelzi (Seladelpar) | Servicio Cántabro de Salud | GILEAD SCIENCES, S.L | €1,078,285 | 19 Oct 2026 |
| Lote 11. Epclusa (Ofosbuvir/Velpatasvir) | Servicio Cántabro de Salud | GILEAD SCIENCES, S.L | €621,599 | 19 Oct 2026 |
| Lote 10. Eviplera (Emtricitabina/Rilpivirina/Tenofovir Disoproxilo Fumarato) | Servicio Cántabro de Salud | GILEAD SCIENCES, S.L | €21,348 | 19 Oct 2026 |
| Lote 9. Genvoya (Emtricitabina/Tenofovir Alafenamida/Elvitegravir/Cobicistat) | Servicio Cántabro de Salud | GILEAD SCIENCES, S.L | €66,611 | 19 Oct 2026 |
| Lote 8. Veklury (Remdesivir) | Servicio Cántabro de Salud | GILEAD SCIENCES, S.L | €445,740 | 19 Oct 2026 |